Enexis (Sweden) Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
18
- Portfolio
-
12
- Exits
-
5
Enexis (Sweden) General Information
Company Description
Founded in 2018, Enexis is a venture capital firm based in Stockholm, Sweden. The firm seeks to invest in plant-based medical, wellness, and industrial applications, notably the cannabis and hemp sectors.
Business Details
Website
www.enexis.seYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Alma, Nybrogatan 8
- 114 34 Stockholm
- Sweden
Enexis (Sweden) Investments (18)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Demecan | 20-Dec-2022 | Later Stage VC | Other Pharmaceuticals and Biotechnology | Generating Revenue | ||
| Valcon Medical | 09-May-2022 | Pharmaceuticals | Generating Revenue | |||
| Lyphe Group | 29-Apr-2022 | Other Healthcare Services | Generating Revenue | |||
| Tetra Pharm Technologies | 15-Dec-2021 | Pharmaceuticals | Generating Revenue | |||
| South West Brands | 04-Oct-2021 | Other Consumer Non-Durables | Generating Revenue | |||
| Prohibition Partners | 01-Jul-2021 | Media and Information Services (B2B) | Generating Revenue | |||
| Northern Leaf | 31-Mar-2021 | Cultivation | Generating Revenue | |||
| Octarine Bio | 11-Mar-2021 | Specialty Chemicals | Clinical Trials - Phase 2 | |||
| Curaleaf International | 04-Mar-2021 | Early Stage VC | Other Pharmaceuticals and Biotechnology | Generating Revenue | ||
| Cannaray | 01-Jan-2021 | Early Stage VC | Other Pharmaceuticals and Biotechnology | Generating Revenue |
Enexis (Sweden) Exits (5)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Infinite Percent Partners | 24-Apr-2026 | Out of Business | |
| Valcon Medical | 01-Jan-2025 | ||
| Lyphe Group | 11-Jan-2024 | ||
| South West Brands | 19-Apr-2023 | Merger/Acquisition | |
| Curaleaf International | 07-Apr-2021 | Merger/Acquisition |
Enexis (Sweden) Investments by Industry, Year, and Region
Enexis (Sweden) Co-Investors (8)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Altitude Investment Management | 1 |
|
|
||
| Artemis Growth Partners |
|
|
|||
| Futury Capital |
|
|
|||
| Greenfield Global |
|
|
|||
| Mittelständische Beteiligungsgesellschaft Sachsen |
|
|
Enexis (Sweden) FAQs
-
What is Enexis (Sweden)?
Founded in 2018, Enexis is a venture capital firm based in Stockholm, Sweden.
-
When was Enexis (Sweden) founded?
Enexis (Sweden) was founded in 2018.
-
Where is Enexis (Sweden) headquartered?
Enexis (Sweden) is headquartered in Stockholm, Sweden.
-
How many investments has Enexis (Sweden) made?
Enexis (Sweden) has made 18 investments.
-
What has Enexis (Sweden) invested in?
Enexis (Sweden) has made numerous investments in companies like Demecan, Valcon Medical, and Lyphe Group within the Pharmaceuticals and Biotechnology, Pharmaceuticals, and Healthcare Services industries.
-
What has Enexis (Sweden) invested in recently?
Enexis (Sweden)'s latest investment was on 20-Dec-2022 in Demecan, a company within the Pharmaceuticals and Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process